Oshrat Levi-Galibov

Oshrat Levi-Galibov

Auto-generated profile, based on publicly available information

Oshrat Levi-Galibov

Department of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot, Israel

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 March 2025 in Cancer Discovery
Verified
Journal Article
Closed access
ABAviad Ben-Shmuel
Aviad Ben-Shmuel
YGYael Gruper
Yael Gruper
CHCoral Halperin
Coral Halperin
OLOshrat Levi-Galibov
Oshrat Levi-Galibov
HRHallel Rosenberg-Fogler
Hallel Rosenberg-Fogler
RSRuth Scherz-Shouval
Ruth Scherz-Shouval
Cancer-associated fibroblasts (CAF) are abundant components of the breast tumor microenvironment and major contributors to immune-modulation. CAFs regulate the activity of many immune cells including T cells, macrophages, and dendritic cells; however, little is known about their interaction with NK cells, which constitute an important arm of antitumor immunity. Using mouse models of breast cancer and ex vivo cocultures, we find that CAFs inhibit NK cell cytotoxicity toward cancer cells. We unravel the mechanism by which suppression occurs, which is through ligand–receptor engagement between NK cells and CAFs, leading to CAF cytolysis and downregulation of activating receptor expression on NK cells, promoting cancer cell escape from NK cell surveillance. In patients with triple-negative breast cancer, we find enrichment of NK cells in CAF-rich regions and upregulation of NK-binding ligands on CAFs, which correlates with poor disease outcomes. These results reveal a CAF-mediated immunosuppressive decoy mechanism with implications for the treatment of carcinomas. Significance: Little is known about the influence of CAFs on NK cells in the context of carcinomas. Here, we mechanistically unravel a pathway of CAF-mediated suppression of NK cells in breast cancer, opening possible avenues for new biomarkers and strategies for immune-based therapies. See related commentary by Sherman, p. 1096

7 August 2023 in Cancer Research
Verified
Journal Article
Closed access
PDF file
NCNoam Cohen
Noam Cohen
DMDhanashree Mundhe
Dhanashree Mundhe
SDSarah K. Deasy
Sarah K. Deasy
OAOmer Adler
Omer Adler
NENour Ershaid
Nour Ershaid
NENeta Erez
Neta Erez
Metastatic cancer is largely incurable and is the main cause of cancer-related deaths. The metastatic microenvironment facilitates formation of metastases. Cancer-associated fibroblasts (CAF) are crucial players in generating a hospitable metastatic niche by mediating an inflammatory microenvironment. Fibroblasts also play a central role in modifying the architecture and stiffness of the extracellular matrix (ECM). Resolving the early changes in the metastatic niche could help identify approaches to inhibit metastatic progression. Here, we demonstrate in mouse models of spontaneous breast cancer pulmonary metastasis that fibrotic changes and rewiring of lung fibroblasts occurred at premetastatic stages, suggesting systemic influence by the primary tumor. Activin A (ActA), a TGFβ superfamily member, was secreted from breast tumors and its levels in the blood were highly elevated in tumor-bearing mice. ActA upregulated the expression of profibrotic factors in lung fibroblasts, leading to enhanced collagen deposition in the lung premetastatic niche. ActA signaling was functionally important for lung metastasis, as genetic targeting of ActA in breast cancer cells significantly attenuated lung metastasis and improved survival. Moreover, high levels of ActA in human patients with breast cancer were associated with lung metastatic relapse and poor survival. This study uncovers a novel mechanism by which breast cancer cells systemically rewire the stromal microenvironment in the metastatic niche to facilitate pulmonary metastasis. Significance: ActA mediates cross-talk between breast cancer cells and cancer-associated fibroblasts in the lung metastatic niche that enhances fibrosis and metastasis, implicating ActA as a potential therapeutic target to inhibit metastatic relapse.

3 June 2025
Verified
Other
Open access
ABAviad Ben-Shmuel
Aviad Ben-Shmuel
YGYael Gruper
Yael Gruper
CHCoral Halperin
Coral Halperin
OLOshrat Levi-Galibov
Oshrat Levi-Galibov
HRHallel Rosenberg-Fogler
Hallel Rosenberg-Fogler
RSRuth Scherz-Shouval
Ruth Scherz-Shouval
Cancer-associated fibroblasts (CAF) are abundant components of the breast tumor microenvironment and major contributors to immune-modulation. CAFs regulate the activity of many immune cells including T cells, macrophages, and dendritic cells; however, little is known about their interaction with NK cells, which constitute an important arm of antitumor immunity. Using mouse models of breast cancer and ex vivo cocultures, we find that CAFs inhibit NK cell cytotoxicity toward cancer cells. We unravel the mechanism by which suppression occurs, which is through ligand–receptor engagement between NK cells and CAFs, leading to CAF cytolysis and downregulation of activating receptor expression on NK cells, promoting cancer cell escape from NK cell surveillance. In patients with triple-negative breast cancer, we find enrichment of NK cells in CAF-rich regions and upregulation of NK-binding ligands on CAFs, which correlates with poor disease outcomes. These results reveal a CAF-mediated immunosuppressive decoy mechanism with implications for the treatment of carcinomas.Significance:Little is known about the influence of CAFs on NK cells in the context of carcinomas. Here, we mechanistically unravel a pathway of CAF-mediated suppression of NK cells in breast cancer, opening possible avenues for new biomarkers and strategies for immune-based therapies.See related commentary by Sherman, p. 1096



3 June 2025
Verified
Other
Open access
PDF file
ABAviad Ben-Shmuel
Aviad Ben-Shmuel
YGYael Gruper
Yael Gruper
CHCoral Halperin
Coral Halperin
OLOshrat Levi-Galibov
Oshrat Levi-Galibov
HRHallel Rosenberg-Fogler
Hallel Rosenberg-Fogler
RSRuth Scherz-Shouval
Ruth Scherz-Shouval
Supplementary Figure 7 shows that Tumor-infiltrating NK cells in human breast cancer may be recruited to and activated by CAFs